Oct 5, 2026 08:01AM
Oct 5, 2026 08:00AM
Sep 14, 2026 08:02AM
Sep 14, 2026 08:00AM
Aug 17, 2026 07:30AM
Aug 17, 2026 07:30AM
Jul 31, 2026 07:01AM Radiopharm RAD 101 meets Phase 2b endpoint in brain metastases
Jul 31, 2026 07:00AM
Jul 22, 2026 07:00AM
Jul 22, 2026 07:00AM
May 14, 2026 09:15AM
Apr 23, 2026 07:00AM
Apr 7, 2026 10:07AM
Apr 7, 2026 07:00AM Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.
Mar 24, 2026 07:00AM
Mar 24, 2026 07:00AM
Jan 28, 2026 07:00AM
Jan 12, 2026 07:03AM
Jan 12, 2026 07:00AM
Dec 15, 2025 07:02AM
Dec 15, 2025 07:00AM Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
Nov 26, 2025 09:11AM
Nov 17, 2025 08:00AM
Oct 20, 2025 08:05AM
Oct 20, 2025 08:00AM
Jul 29, 2025 07:30AM
Jul 28, 2025 08:02AM
Jul 28, 2025 08:00AM Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)
Jul 22, 2025 09:04AM
Jul 22, 2025 08:00AM
Jun 11, 2025 08:00AM
Jun 2, 2025 08:00AM
May 19, 2025 08:00AM
Mar 12, 2025 03:32AM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All